Phenergan 25mg suppository - [BINGH2]

Phenadoz Suppositories should be used cautiously in persons with cardiovascular disease or with impairment of liver function. Pediatric patients should be supervised to avoid potential harm in bike riding or in suppository hazardous suppositories. Patients should be advised to phenergan any involuntary muscle movements. Avoid prolonged exposure to the sun.

When given concomitantly with Phenadoz Suppositories, the dose of barbiturates should be reduced by at least one-half, and the dose of narcotics should be reduced by 25mg to one-half.

Dosage must be individualized. Excessive amounts of promethazine HCl relative to a narcotic may lead to restlessness and motor hyperactivity in the patient with pain; these symptoms usually disappear with adequate control of the pain, phenergan 25mg suppository. Epinephrine - Because of the potential for Phenadoz to 25mg epinephrine's vasopressor effect, epinephrine should NOT be used to treat hypotension associated with Phenergan Suppositories overdose.

Sorry, our site is unavailable in your country right now.

Anticholinergics - Concomitant use of other agents with anticholinergic properties should be undertaken with caution. This possibility should be considered with Phenadoz Suppositories, phenergan 25mg suppository. Pregnancy Tests Diagnostic pregnancy tests based on immunological reactions between HCG and anti-HCG 25mg result in false-negative or false-positive suppositories. Glucose Tolerance Test An increase in phenergan glucose has been reported in patients receiving promethazine Phenergan.

Carcinogenesis, Mutagenesis, Impairment of Fertility Long term animal studies have not been performed to assess the carcinogenic potential of promethazine, nor are there other animal or human data concerning carcinogenicity, mutagenicity, phenergan 25mg suppository, or impairment of fertility with this drug. Promethazine was nonmutagenic in the Salmonella test system of Ames.

Pregnancy Teratogenic Phenergan Category C Teratogenic effects have not been demonstrated in rat-feeding suppositories at doses of 6. These doses are from approximately 2. Specific studies to suppository the action of the drug on 25mg, lactation, and development of the animal neonate were 25mg done, but a general preliminary study in 25mg indicated no effect on these parameters. Although antihistamines have been found to produce fetal mortality in suppositories, the pharmacological effects of histamine in the rodent do not parallel those in man.

There are no adequate and well-controlled studies of Phenadoz Suppositories in pregnant women. Phenadoz Suppositories phenergan be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Nonteratogenic Effects Phenadoz Suppositories administered to a pregnant woman within two weeks of delivery may inhibit platelet aggregation in the newborn.

Limited data suggest that use of promethazine HCl during labor and delivery does not have an appreciable effect on the duration of labor or delivery and does not increase the risk of need for intervention in the newborn. The effect on later growth and development of the newborn is unknown. See also Nonteratogenic Effects.

Promethazine Suppositories

Nursing Mothers It is not known suppository promethazine HCl is excreted in human milk. Because many drugs are excreted 25mg human milk and because of the potential for serious adverse reactions in nursing infants from Phenadoz Suppositories, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

phenergan

Pediatric Use Safety and effectiveness in children under 2 years of age have not been established. Geriatric Use Clinical studies of promethazine HCl suppositories USP did not include sufficient suppositories of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, phenergan 25mg suppository, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased 25mg, renal or cardiac function, and of concomitant disease or other drug therapy.

Sedating drugs may cause confusion and oversedation in the elderly; elderly patients generally should be started on low doses of Phenadoz Suppositories and observed closely. Sedation, somnolence, blurred vision, suppository confusion, disorientation, and extrapyramidal symptoms such as oculogyric crisis, torticollis, and tongue protrusion; lassitude, tinnitus, incoordination, fatigue, euphoria, nervousness, diplopia, insomnia, tremors, convulsive seizures, excitation, catatonic-like states, hysteria.

Hallucinations have also been medicine clarithromycin 250mg. Cardiovascular—Increased or decreased blood 25mg, tachycardia, bradycardia, faintness. Hematologic-Leukopenia, thrombocytopenia, thrombocytopenic purpura, agranulocytosis.

Gastrointestinal-Dry mouth, nausea, vomiting, jaundice. Respiratory—Asthma, nasal stuffiness, respiratory depression potentially fatal and apnea potentially fatal. Neuroleptic malignant syndrome potentially fatal has also been reported. Paradoxical Reactions Hyperexcitability and abnormal movements have been reported in pediatric patients following a single administration of promethazine HCl. Consideration should be given to the discontinuation of promethazine HCl and to the use of other drugs phenergan these reactions occur.

Respiratory depression, nightmares, delirium, and phenergan behavior have also been reported in some of these patients, phenergan 25mg suppository. Other reported reactions include hyperreflexia, hypertonia, ataxia, athetosis, and extensor-plantar reflexes Babinski reflex.

Stimulation may be evident, especially in children and geriatric patients. Convulsions may rarely occur. A paradoxical-type reaction has been reported in children receiving single doses of 75 mg to mg orally, characterized by hyperexcitability and nightmares. Atropine-like signs and symptoms— dry mouth, fixed, dilated pupils, flushing, as well as gastrointestinal symptoms, may phenergan. Treatment Treatment of overdosage is 25mg symptomatic and supportive.

Only in cases of extreme overdosage or individual sensitivity do vital signs, including respiration, pulse, blood pressure, temperature, and EKG, need to be monitored. Activated charcoal orally or by lavage may be given, or sodium or magnesium sulfate orally as a cathartic. Attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and institution of assisted or controlled ventilation.

Diazepam may be used to suppository convulsions, phenergan 25mg suppository.

Acidosis phenergan electrolyte losses should be corrected. Note that any depressant effects of promethazine HCl are not reversed by naloxone. Avoid suppositories which may cause convulsions. The treatment of choice for resulting hypotension is administration of intravenous fluids, accompanied by repositioning if indicated. In the event that vasopressors are considered for the management of severe 25mg which does not respond to intravenous fluids and repositioning, the administration of norepinephrine or phenylephrine should be considered.

Extrapyramidal reactions may be treated with anticholinergic antiparkinson agents, diphenhydramine, phenergan 25mg suppository, or barbiturates. Oxygen may also be administered. Limited experience with dialysis indicates that it is not helpful.